High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [6]

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)91-93
Number of pages3
JournalNew England Journal of Medicine
Volume358
Issue number1
DOIs
StatePublished - Jan 3 2008

Fingerprint

Immunoglobulin Light Chains
Melphalan
Amyloidosis
Combination Drug Therapy
Dexamethasone
Myeloablative Agonists

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{c56fc63b8b434e71a02e7d885b4706b5,
title = "High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [6]",
author = "Kumar, {Shaji K} and Angela Dispenzieri and Morie Gertz",
year = "2008",
month = "1",
day = "3",
doi = "10.1056/NEJMc072918",
language = "English (US)",
volume = "358",
pages = "91--93",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "Massachussetts Medical Society",
number = "1",

}

TY - JOUR

T1 - High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [6]

AU - Kumar, Shaji K

AU - Dispenzieri, Angela

AU - Gertz, Morie

PY - 2008/1/3

Y1 - 2008/1/3

UR - http://www.scopus.com/inward/record.url?scp=38049048267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049048267&partnerID=8YFLogxK

U2 - 10.1056/NEJMc072918

DO - 10.1056/NEJMc072918

M3 - Letter

VL - 358

SP - 91

EP - 93

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 1533-4406

IS - 1

ER -